TNFR2 activates mlck-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis

Gastroenterology

Volumn 145, Issue 2, 2013, Pages 407-415

  Su, Liping ^a,b   Nalle, Sam C ^b   Shen, Le ^b   Turner, Emily S ^b   Singh, Gurminder ^b   Breskin, Lydia A ^b   Khramtsova, Ekaterina A ^b   Khramtsova, Galina ^b   Tsai, Pei Yun ^b   Fu, Yang Xin ^b   Abraham, Clara ^c   Turner, Jerrold R ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammatory Bowel Disease Epithelial Barrier Intestinal Permeability Disease Progression

Indexed keywords

CLAUDIN 2; MYOSIN II; MYOSIN LIGHT CHAIN KINASE; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EXPERIMENTAL COLITIS; INTESTINE MOTILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TIGHT JUNCTION; UPREGULATION;

EID: 84880611949     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.04.011     Document Type: Article

References (40)

1. L. Su, L. Shen, and D.R. Clayburgh Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis Gastroenterology 136 2009 551 563
2. S. Vetrano, M. Rescigno, and M. Rosaria Cera Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease Gastroenterology 135 2008 173 184
3. M.G. Laukoetter, P. Nava, and W.Y. Lee JAM-A regulates permeability and inflammation in the intestine in vivo J Exp Med 204 2007 3067 3376
4. A.H. Gitter, F. Wullstein, and M. Fromm Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging Gastroenterology 121 2001 1320 1328
5. R. Atreya, M. Zimmer, and B. Bartsch Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14(+) macrophages Gastroenterology 141 2011 2026 2038
6. F. Wang, B.T. Schwarz, and W.V. Graham IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction Gastroenterology 131 2006 1153 1163
7. E. Mizoguchi, A. Mizoguchi, and H. Takedatsu Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice Gastroenterology 122 2002 134 144
8. J. Corredor, F. Yan, and C.C. Shen Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms Am J Physiol Cell Physiol 284 2003 C953 C961
9. B.W. Behm, and S.J. Bickston Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease Cochrane Database Syst Rev 2008 CD006893
10. P. Rutgeerts, W.J. Sandborn, and B.G. Feagan Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2005 2462 2476
11. D.R. Clayburgh, T.A. Barrett, and Y. Tang Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo J Clin Invest 115 2005 2702 2715
12. F. Heller, P. Florian, and C. Bojarski Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution Gastroenterology 129 2005 550 564
13. S.A. Blair, S.V. Kane, and D.R. Clayburgh Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease Lab Invest 86 2006 191 201
14. F. Powrie, M.W. Leach, and S. Mauze Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells Immunity 1 1994 553 662
15. P. Suenaert, P. Maerten, and G. Van Assche Effects of T cell-induced colonic inflammation on epithelial barrier function Inflamm Bowel Dis 16 2010 1322 1331
16. X. Liu, J. Xu, and Q. Mei Myosin light chain kinase inhibitor inhibits dextran sulfate sodium-induced colitis in mice Dig Dis Sci 58 2013 107 114
17. K.E. Kamm, and J.T. Stull Dedicated myosin light chain kinases with diverse cellular functions J Biol Chem 276 2001 4527 4530
18. J. Bain, H. McLauchlan, and M. Elliott The specificities of protein kinase inhibitors: an update Biochem J 371 2003 199 204
19. D.R. Clayburgh, S. Rosen, and E.D. Witkowski A differentiation-dependent splice variant of myosin light chain kinase, MLCK1, regulates epithelial tight junction permeability J Biol Chem 279 2004 55506 55513
20. W.Q. He, Y.J. Peng, and W.C. Zhang Myosin light chain kinase is central to smooth muscle contraction and required for gastrointestinal motility in mice Gastroenterology 135 2008 610 620
21. J. Xu, X.P. Gao, and R. Ramchandran Nonmuscle myosin light-chain kinase mediates neutrophil transmigration in sepsis-induced lung inflammation by activating beta2 integrins Nat Immunol 9 2008 880 886
22. J. Wyatt, H. Vogelsang, and W. Hubl Intestinal permeability and the prediction of relapse in Crohn's disease Lancet 341 1993 1437 1439
23. K. Miki, D.J. Moore, and R.N. Butler The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease J Pediatr 133 1998 750 754
24. D. Hollander, C.M. Vadheim, and E. Brettholz Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor Ann Intern Med 105 1986 883 885
25. Y. Zolotarevsky, G. Hecht, and A. Koutsouris A membrane-permeant peptide that inhibits MLC kinase restores barrier function in invitro models of intestinal disease Gastroenterology 123 2002 163 172
26. B.T. Schwarz, F. Wang, and L. Shen LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms Gastroenterology 132 2007 2383 2394
27. R. Al-Sadi, D. Ye, and K. Dokladny Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability J Immunol 180 2008 5653 5661
28. C.R. Weber, D.R. Raleigh, and L. Su Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity J Biol Chem 285 2010 12037 12046
29. W.J. Sandborn, J.F. Colombel, and R. Enns Natalizumab induction and maintenance therapy for Crohn's disease N Engl J Med 353 2005 1912 1925
30. G. D'Haens, S. Van Deventer, and R. Van Hogezand Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial Gastroenterology 116 1999 1029 1034
31. G. Jarnerot, E. Hertervig, and I. Friis-Liby Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study Gastroenterology 128 2005 1805 1811
32. B.C. Sydora, N. Wagner, and J. Lohler beta7 Integrin expression is not required for the localization of T cells to the intestine and colitis pathogenesis Clin Exp Immunol 129 2002 35 42
33. C. Shen, G. de Hertogh, and D.M. Bullens Remission-inducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization? Inflamm Bowel Dis 13 2007 308 316
34. M.D. Deboer, J. Steinman, and Y. Li Partial normalization of pubertal timing in female mice with DSS colitis treated with anti-TNF-alpha antibody J Gastroenterol 47 2012 647 654
35. K.A. Waschke, A.-C. Villani, and S. Vermeire Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes Am J Gastroenterol 100 2005 1126 1133
36. K. Wang, G. Han, and Y. Dou Opposite role of tumor necrosis factor receptors in dextran sulfate sodium-induced colitis in mice PLoS ONE 7 2012 e52924
37. E. Mizoguchi, Y. Hachiya, and M. Kawada TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality Gastroenterology 134 2008 470 480
38. R. Stillie, and A.W. Stadnyk Role of TNF receptors, TNFR1 and TNFR2, in dextran sodium sulfate-induced colitis Inflamm Bowel Dis 15 2009 1515 1525
39. J.M. Russo, P. Florian, and L. Shen Distinct temporal-spatial roles for rho kinase and myosin light chain kinase in epithelial purse-string wound closure Gastroenterology 128 2005 987 1001
40. L. Shen, C.R. Weber, and D.R. Raleigh Tight junction pore and leak pathways: a dynamic duo Annu Rev Physiol 73 2011 283 309